Why You Should Stop Bashing Millennials

Maggie Kimberl  |

Millennial bashing is so last year. Time and time again stats have shown that Millennials actually do face real-world struggles, from ballooning housing prices to stagnating wages to crushing student loan debt. The realities Millennials face these days are completely different than those of their predecessors, and that often translates to completely foreign struggles with no frame of reference to go by. When you break it down, Millennials are actually doing pretty well.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.